ArticleTranslational lung cancer research2021

Interactions between epidermal growth factor receptor tyrosine kinase inhibitors and proton-pump inhibitors/histamine type-2 receptor antagonists in non-small cell lung cancer: a systematic review and meta-analysis.

Wilson Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.